{"id":72396,"date":"2013-02-12T09:50:52","date_gmt":"2013-02-12T14:50:52","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/reproductive-medicine-associates-of-new-jersey-releases-2011-ivf-success-rates.php"},"modified":"2013-02-12T09:50:52","modified_gmt":"2013-02-12T14:50:52","slug":"reproductive-medicine-associates-of-new-jersey-releases-2011-ivf-success-rates","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/reproductive-medicine-associates-of-new-jersey-releases-2011-ivf-success-rates.php","title":{"rendered":"Reproductive Medicine Associates Of New Jersey Releases 2011 IVF Success Rates"},"content":{"rendered":"<p><p>    BASKING RIDGE, N.J., Feb. 11, 2013 \/PRNewswire\/    --Reproductive Medicine Associates of New Jersey    (RMANJ) has released in vitro fertilization (IVF) success rates    for the year ending December 2011, showing a marked increase in    successful pregnancies and live births per cycle    initiated. RMANJ, a world-renowned leader in the field of    Assisted Reproductive Technology (ART),    credits the continued increase in successful pregnancies to    their pioneering research in the areas of blastocyst embryo    transfer, SelectCCS (Comprehensive Chromosome    Screening), trophectoderm biopsy (TE) of embryos for    genetic testing, and Single Embryo Transfer (SET).  <\/p>\n<p>    (Logo: <a href=\"http:\/\/photos.prnewswire.com\/prnh\/20120402\/NY80340LOGO\" rel=\"nofollow\">http:\/\/photos.prnewswire.com\/prnh\/20120402\/NY80340LOGO<\/a>    )  <\/p>\n<p>    The 2011 data is based on pregnancy and delivery rates of    nearly 2,000 treatment cycles across all age groups.    Information is governed by The Society of Assisted Reproductive    Technology (SART), the primary organization of professionals    dedicated to the practice of Assisted Reproductive Technologies    in the United States. RMANJ's full Clinic Summary Report can be    viewed at <a href=\"http:\/\/www.sart.org\" rel=\"nofollow\">http:\/\/www.sart.org<\/a>.  <\/p>\n<p>    RMANJ continues to outpace the nation with this latest data    showing a live birth rate per cycle initiated of 64.4% in women    under 35 years of age. The average number of embryos    transferred in this age group was 1.8.  <\/p>\n<p>    SART Pregnancy Success Rates in Women Under 35 Years  <\/p>\n<p>            Fresh Embryo Cycles (non-donor            eggs)          <\/p>\n<p>            RMANJ          <\/p>\n<p>            Nation          <\/p>\n<p>            Percent of embryos transferred            resulting in implantation          <\/p>\n<p>            62.5%          <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/reproductive-medicine-associates-jersey-releases-140000602.html;_ylt=A2KLOzG3VhpRxioAfKD_wgt.\" title=\"Reproductive Medicine Associates Of New Jersey Releases 2011 IVF Success Rates\">Reproductive Medicine Associates Of New Jersey Releases 2011 IVF Success Rates<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> BASKING RIDGE, N.J., Feb. 11, 2013 \/PRNewswire\/ --Reproductive Medicine Associates of New Jersey (RMANJ) has released in vitro fertilization (IVF) success rates for the year ending December 2011, showing a marked increase in successful pregnancies and live births per cycle initiated.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/reproductive-medicine-associates-of-new-jersey-releases-2011-ivf-success-rates.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-72396","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/72396"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=72396"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/72396\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=72396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=72396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=72396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}